Cheol Young Choi
Sungkyunkwan University · 医学
研究室紹介
Professor Cheol Young Choi's research lab specializes in ophthalmic biomaterials and intraocular lens (IOL) technology, with a focus on improving visual outcomes and patient quality of life following cataract surgery. The lab investigates advanced IOL designs—particularly extended depth of focus (EDOF) and multifocal IOLs—comparing their optical performance, biocompatibility, and clinical tolerance to refractive errors. Research also extends to dry eye disease (DES) therapeutics, evaluating novel agents like Clacier for symptom relief and efficacy. Additionally, the lab examines postoperative intraocular pressure (IOP) dynamics and contamination risks in ocular surface therapies.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Preservative-free artificial tears in reclosable containers are at risk of contamination in a daily and multiple use setting, especially in patients with a poor administering technique, which is associated with fingertip touch and advanced age.
BACKGROUND: To evaluate the clinical outcomes of extended depth of focus (EDOF) and monofocal intraocular lenses (IOLs) that share identical aspheric platform and compare their visual acuity tolerance to postoperative refractive errors. METHODS: This non-randomized, prospective comparative study included 120 eyes undergoing cataract surgery with implantation of either Tecnis ZCB00 IOL (Abbott Medical Optics Inc., Santa Ana, CA) (monofocal group: 60 eyes of 30 patients) or Tecnis Symfony IOL (Abb
We found a significant decrease in IOP after cataract surgery in nonglaucoma patients. However, change of diurnal IOP fluctuation after surgery was not statistically different. These results can be used as baseline data for diurnal IOP fluctuation studies in glaucoma patients after cataract surgery.
BACKGROUND: To experimentally compare the optical performance of two different Extended-Depth-of-Focus (EDOF) intraocular lenses (IOLs) using a standardized optical bench set-up. METHODS: In this experimental study, following IOLs were assessed: the TECNIS® Symfony ZXR00 (Johnson&Johnson, Santa Ana, USA) and the AT LARA 829MP (Carl Zeiss Meditec, Jena, Germany) IOLs. The through-focus modulation transfer function (MTF) values were measured at a spatial frequency of 50 lp/mm and at aperture sizes
Treatment with Clacier alleviated clinical signs and symptoms of DES comparably to the commercially available Restasis, resulting in improved quality of life for patients. Clacier is an effective and safe therapeutic agent for DES.
BACKGROUND: To compare the clinical outcomes of bilateral implantation of enhanced intermediate function intraocular lenses (IOLs) and standard monofocal IOLs. METHODS: In this prospective, randomized, comparative controlled study, we compared the visual outcomes of patients who underwent bilateral cataract surgery at the Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, with either enhanced monofocal IOLs (Tecnis Eyhance, ICB00, Johnson and Johnson Vision Care, Inc) (Group 1
AIMS: The associations of visual impairment (VI) with cardio-metabolic risk factors have been reported but its association with cardiovascular mortality remains uncertain. Therefore, we evaluated the association of visual acuity (VA) with overall, injury-related, and cardiovascular mortality. METHODS AND RESULTS: A cohort study was performed in 580 746 Korean adults (average age, 39.7 years) who were followed for a median of 8.1 years (maximum, 16 years). Presenting VA was measured by the Early
AS-OCT offers a fast easy method for evaluating human donor corneas for corneal thickness and structural changes without the risk of bacterial contamination or mechanical damage.
Purpose. To evaluate monocular and binocular visual performance and patient-reported outcomes following combined implantation of a diffractive extended depth of focus (EDoF) IOL (Carl Zeiss AT LARA 829MP) and a diffractive trifocal IOL (Carl Zeiss AT LISA tri 839MP). Methods. This prospective study enrolled consecutive patients undergoing lens phacoemulsification of cataract and combined implantation of an EDoF IOL in the dominant eye and a trifocal IOL in the nondominant eye. Assessment include
<h4>PURPOSE</h4><p>To evaluate various methods of surface ablation by comparing the integrity of basal epithelial cells and the basement membrane using transmission electron microscopy.</p> <h4>METHODS</h4><p>Corneal epithelial flaps were created using four approaches: mechanical removal (using a blunt spatula after application of 0.5% proparacaine, mechanical group); conventional LASEK (after application of 20% alcohol for 20 seconds, LASEK group); epi-
PURPOSE: To compare clinical outcomes of bilateral implantation of hybrid multifocal intraocular lenses (IOLs) versus mix-and-match implantation of hybrid multifocal and extended-depth-of-focus (EDOF) versus mix-and-match implantation of hybrid multifocal and enhanced monofocal IOLs. METHODS: Patients with bilateral age-related cataract were randomised in one of three groups: group 1, bilateral hybrid multifocal IOL; group 2, EDOF in the dominant eye, hybrid multifocal in the non-dominant eye; g
Research Areas
Cheol Young Choiの研究をNubintでさらに深く
この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。